Display Settings:

Format

Send to:

Choose Destination
    Curr Opin Hematol. 1999 Nov;6(6):400-5.

    Hematopoietic stem cell transplantation for autoimmune disorders.

    Source

    Division of Hematology, Kantonsspital Basel, Switzerland. passweg@ubaclu.unibas.ch

    Abstract

    Autologous hemopoietic stem cell transplantation (HSCT) for autoimmune disease has increased lately. Insights into response to immunoablation is found in animal experiments and reports on patients receiving HSCT for concomitant malignancy. Early phase II studies and case reports of HSCT in patients with multiple sclerosis, systemic sclerosis, lupus erythematosus, rheumatoid arthritis, juvenile chronic arthritis and idiopathic thrombocytopenic purpura have been published. Dramatic responses or disease stabilization have been observed in some, but failures and disease relapses, toxic and infectious complications have been observed in others. Whether this treatment can induce true peripheral immunologic tolerance, and which been observed if any patients will benefit long-term from HSCT, remains to be determined.

    PMID:
    10546794
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk